Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-21 4:21 pm Sale | 13D | Icosavax Inc. ICVX | Qiming U.S. Healthcare GP II LLC | 0 0.000% | -3,523,561 (Position Closed) | View |
| 2024-01-09 4:24 pm Sale | 13G | ELEVATION ONCOLOGY INC ELEV | Qiming U.S. Healthcare GP II LLC | 0 0.000% | -2,370,142 (Position Closed) | View |
| 2023-10-30 4:15 pm Purchase | 13D | TOURMALINE BIO INC TRML | Qiming U.S. Healthcare GP II LLC | 646,770 3.200% | 646,770 (New Position) | View |
| 2022-02-28 4:03 pm Purchase | 13D | TOURMALINE BIO INC TRML | Qiming U.S. Healthcare GP II LLC | 2,983,398 7.200% | 2,983,398 (New Position) | View |
| 2022-02-28 4:02 pm Purchase | 13D | Icosavax Inc. ICVX | Qiming U.S. Healthcare GP II LLC | 3,523,561 9.000% | 3,523,561 (New Position) | View |
| 2022-02-08 4:15 pm Purchase | 13G | ELEVATION ONCOLOGY INC ELEV | Qiming U.S. Healthcare GP II LLC | 2,370,142 10.200% | 2,370,142 (New Position) | View |